CMA accuses pharmaceutical companies of overcharge the NHS for vital anti-epilepsy drugs

After reexamining the case, the CMA provisionally concluded that Pfizer and Flynn exploited their dominant positions to overcharge the NHS for critical anti-epilepsy medications. The

Read more